Alldigi Tech Ltd

Q3 FY23 Earnings Call Analysis

Commercial Services & Supplies

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- Allsec Technologies Limited currently holds a significant cash balance (around INR 100+ crores post dividend payout). - Management is evaluating optimal use of cash, including organic investments and potential inorganic acquisitions. - There is no indication of immediate or concrete plans for new fundraising through debt or equity at present. - The company is considering niche vertical acquisitions or geographic expansions, particularly in the US, but nothing materialized yet. - Focus remains on balancing internal returns, sustainable dividend policy, and potential acquisitions. - No explicit mention of fresh fundraising plans in the recent call or transcript.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Allsec Technologies is focused on optimizing cash use, considering both organic and inorganic investments. - They are actively evaluating niche vertical acquisitions and expanding geographic presence in the US, particularly in CXM and EXM segments, though no concrete acquisitions are currently on the table. - Internal investments continue in people, process, and technology, with recent capitalization of key platforms like SmartPay 4 (SP4) and a new HRMS platform as of September 30, 2023. - Transition plans are underway to migrate customers to SP4 and launch HRMS on a SaaS basis, targeting new market segments with a focus on profitable client acquisition. - The company maintains a sizable cash reserve (over INR 100 crores post-dividend) and a portion is invested in mutual funds yielding reasonable returns. - Dividend policy is balanced alongside reinvestment considerations, and capital allocation is reviewed quarterly.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Allsec expects continued growth in both CXM (Customer Experience Management) and EXM (Employee Experience Management) verticals, with higher focus on international sales, especially in EXM. - EXM sales have shown strong momentum, with ACV nearly doubling year-over-year, and the company aims to exceed last year's EXM sales numbers. - Incremental sales growth is a key focus, supported by augmenting sales capacity locally and internationally planned for FY'25. - International sales have crossed over 50% of total new sales and are expected to remain a significant growth driver. - Growth drivers include increased ticket size of new EXM sales, shorter transition timelines, and platform upgrades such as the capitalization of SmartPay 4 and a new HRMS platform ready for market. - Operational efficiencies and service excellence will continue to be emphasized to retain and mine existing customers. - Targeted conversion of competitor logos and new marquee logos are part of the sales strategy.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Management does not provide precise future financial guidance but assures continuation of incremental sales growth. - Focus on increasing international business sales and operational efficiencies to improve profitability. - Platform upgrades (SmartPay 4 and new HRMS) completed and expected to support revenue growth going forward. - EXM segment shows strong growth with a 40% increase in new sales ACV in H1 FY '24 versus previous H2. - Momentum in EXM sales and employee record volumes indicate sustained growth prospects. - International sales, especially in EXM, identified as a key strategic growth driver for FY '25. - Operational excellence and cost efficiency initiatives expected to aid margin improvement. - Quarterly dividend declared reflects confidence in balanced cash utilization and sustainable dividend policy. - Chapter 11 related delinquency has impacted CXM margins but management expects this to be contained going forward.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The company discussed sales achievements in Q2 FY '24 with EXM sales ACV of INR17 crores in H1 FY '24, a 40% increase compared to previous H2 FY '23. - In CXM, two new lines of business were added in a healthcare account, along with two new logos with an ACV exceeding INR5 crores in Q2. - The management indicated a continued focus on international sales growth and plans to augment sales capacity for FY '25. - There is no explicit mention of a detailed current or expected order book or pending orders figure in the transcript. - Management highlighted pipeline growth and strategic initiatives focused on expanding new client acquisitions and international geography presence. - Overall, momentum in new sales and channel partnerships has increased, showing a positive outlook on order inflow and book growth.